These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of comorbidities on the mortality in patients with SARS-CoV-2 infection: an Italian cohort study. Vergara P; Rossi L; Biagi A; Falasconi G; Pannone L; Zanni A; Sticozzi C; Comastri G; Gandolfi S; Godino C; Malagoli A; Villani GQ Minerva Med; 2023 Apr; 114(2):185-190. PubMed ID: 33913658 [TBL] [Abstract][Full Text] [Related]
8. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. McQueenie R; Foster HME; Jani BD; Katikireddi SV; Sattar N; Pell JP; Ho FK; Niedzwiedz CL; Hastie CE; Anderson J; Mark PB; Sullivan M; O'Donnell CA; Mair FS; Nicholl BI PLoS One; 2020; 15(8):e0238091. PubMed ID: 32817712 [TBL] [Abstract][Full Text] [Related]
9. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Iaccarino G; Grassi G; Borghi C; Ferri C; Salvetti M; Volpe M; Hypertension; 2020 Aug; 76(2):366-372. PubMed ID: 32564693 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115 [TBL] [Abstract][Full Text] [Related]
11. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort. Atkins JL; Masoli JAH; Delgado J; Pilling LC; Kuo CL; Kuchel GA; Melzer D J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2224-2230. PubMed ID: 32687551 [TBL] [Abstract][Full Text] [Related]
12. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. Ge E; Li Y; Wu S; Candido E; Wei X PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047 [TBL] [Abstract][Full Text] [Related]
13. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study. Kuan V; Denaxas S; Patalay P; Nitsch D; Mathur R; Gonzalez-Izquierdo A; Sofat R; Partridge L; Roberts A; Wong ICK; Hingorani M; Chaturvedi N; Hemingway H; Hingorani AD; Lancet Digit Health; 2023 Jan; 5(1):e16-e27. PubMed ID: 36460578 [TBL] [Abstract][Full Text] [Related]
14. Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England. Heald AH; Jenkins DA; Williams R; Mudaliar RN; Khan A; Syed A; Sattar N; Khunti K; Naseem A; Bowden-Davies KA; Gibson JM; Ollier W; Diabetes Ther; 2023 Dec; 14(12):2031-2042. PubMed ID: 37620452 [TBL] [Abstract][Full Text] [Related]
15. Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database. Carmona-Pírez J; Ioakeim-Skoufa I; Gimeno-Miguel A; Poblador-Plou B; González-Rubio F; Muñoyerro-Muñiz D; Rodríguez-Herrera J; Goicoechea-Salazar JA; Prados-Torres A; Villegas-Portero R Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409489 [TBL] [Abstract][Full Text] [Related]
16. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak. Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837 [TBL] [Abstract][Full Text] [Related]
17. Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations. Salo H; Lehtonen T; Auranen K; Baum U; Leino T Vaccine; 2022 May; 40(24):3345-3355. PubMed ID: 35489984 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Elliott J; Bodinier B; Whitaker M; Delpierre C; Vermeulen R; Tzoulaki I; Elliott P; Chadeau-Hyam M Eur J Epidemiol; 2021 Mar; 36(3):299-309. PubMed ID: 33587202 [TBL] [Abstract][Full Text] [Related]
19. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients. Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857 [TBL] [Abstract][Full Text] [Related]
20. Current tobacco smoking and risk of SARS-CoV-2 infection and hospitalization: Evaluating the role of socio-demographic factors and comorbidities. Young-Wolff KC; Slama N; Sakoda LC; Prochaska JJ; Fogelberg R; Alexeeff SE Prev Med; 2023 Jul; 172():107523. PubMed ID: 37116761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]